Funding opportunity: Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D

Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a) for CBRN threats.

Applications must demonstrate how the proposed research will result in improved domestic preparedness for CBRN threats.

There is a funding limit of £4 million per application and requested costs should be appropriate to the project. MRC will fund 80% of the full economic cost (FEC).

The duration of your project should be up to 30 months.